cr-5871 protocol v4.0 redacted - clinicaltrials.gov...cr-5871 protocol v4.0 (4) page 9 of 141...
TRANSCRIPT
![Page 1: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/1.jpg)
CR-5871 Protocol v4.0 (4) Page 1 of 141
CONFIDENTIAL
![Page 2: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/2.jpg)
CR-5871 Protocol v4.0 (4) Page 2 of 141
CONFIDENTIAL
![Page 3: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/3.jpg)
CR-5871 Protocol v4.0 (4) Page 3 of 141
CONFIDENTIAL
![Page 4: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/4.jpg)
CR-5871 Protocol v4.0 (4) Page 4 of 141
CONFIDENTIAL
![Page 5: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/5.jpg)
CR-5871 Protocol v4.0 (4) Page 5 of 141
CONFIDENTIAL
![Page 6: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/6.jpg)
![Page 7: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/7.jpg)
CR-5871 Protocol v4.0 (4) Page 7 of 141
CONFIDENTIAL
![Page 8: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/8.jpg)
![Page 9: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/9.jpg)
CR-5871 Protocol v4.0 (4) Page 9 of 141
CONFIDENTIAL
![Page 10: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/10.jpg)
![Page 11: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/11.jpg)
CR-5871 Protocol v4.0 (4) Page 11 of 141
CONFIDENTIAL
![Page 12: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/12.jpg)
CR-5871 Protocol v4.0 (4) Page 12 of 141
CONFIDENTIAL
![Page 13: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/13.jpg)
![Page 14: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/14.jpg)
![Page 15: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/15.jpg)
![Page 16: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/16.jpg)
CR-5871 Protocol v4.0 (4) Page 16 of 141
CONFIDENTIAL
![Page 17: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/17.jpg)
![Page 18: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/18.jpg)
![Page 19: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/19.jpg)
![Page 20: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/20.jpg)
CR-5871 Protocol v4.0 (4) Page 20 of 141
CONFIDENTIAL
![Page 21: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/21.jpg)
![Page 22: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/22.jpg)
![Page 23: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/23.jpg)
![Page 24: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/24.jpg)
![Page 25: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/25.jpg)
![Page 26: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/26.jpg)
![Page 27: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/27.jpg)
![Page 28: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/28.jpg)
![Page 29: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/29.jpg)
![Page 30: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/30.jpg)
![Page 31: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/31.jpg)
CR-5871 Protocol v4.0 (4) Page 31 of 141
CONFIDENTIAL
![Page 32: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/32.jpg)
CR-5871 Protocol v4.0 (4) Page 32 of 141
CONFIDENTIAL
![Page 33: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/33.jpg)
CR-5871 Protocol v4.0 (4) Page 33 of 141
CONFIDENTIAL
![Page 34: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/34.jpg)
CR-5871 Protocol v4.0 (4) Page 34 of 141
CONFIDENTIAL
![Page 35: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/35.jpg)
CR-5871 Protocol v4.0 (4) Page 35 of 141
CONFIDENTIAL
![Page 36: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/36.jpg)
CR-5871 Protocol v4.0 (4) Page 36 of 141
CONFIDENTIAL
![Page 37: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/37.jpg)
CR-5871 Protocol v4.0 (4) Page 37 of 141
CONFIDENTIAL
![Page 38: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/38.jpg)
CR-5871 Protocol v4.0 (4) Page 38 of 141
CONFIDENTIAL
![Page 39: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/39.jpg)
CR-5871 Protocol v4.0 (4) Page 39 of 141
CONFIDENTIAL
![Page 40: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/40.jpg)
CR-5871 Protocol v4.0 (4) Page 40 of 141
CONFIDENTIAL
![Page 41: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/41.jpg)
CR-5871 Protocol v4.0 (4) Page 41 of 141
CONFIDENTIAL
![Page 42: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/42.jpg)
CR-5871 Protocol v4.0 (4) Page 42 of 141
CONFIDENTIAL
![Page 43: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/43.jpg)
CR-5871 Protocol v4.0 (4) Page 43 of 141
CONFIDENTIAL
![Page 44: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/44.jpg)
CR-5871 Protocol v4.0 (4) Page 44 of 141
CONFIDENTIAL
![Page 45: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/45.jpg)
CR-5871 Protocol v4.0 (4) Page 45 of 141
CONFIDENTIAL
![Page 46: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/46.jpg)
CR-5871 Protocol v4.0 (4) Page 46 of 141
CONFIDENTIAL
![Page 47: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/47.jpg)
CR-5871 Protocol v4.0 (4) Page 47 of 141
CONFIDENTIAL
![Page 48: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/48.jpg)
CR-5871 Protocol v4.0 (4) Page 48 of 141
CONFIDENTIAL
![Page 49: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/49.jpg)
CR-5871 Protocol v4.0 (4) Page 49 of 141
CONFIDENTIAL
![Page 50: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/50.jpg)
![Page 51: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/51.jpg)
![Page 52: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/52.jpg)
![Page 53: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/53.jpg)
![Page 54: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/54.jpg)
![Page 55: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/55.jpg)
![Page 56: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/56.jpg)
![Page 57: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/57.jpg)
![Page 58: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/58.jpg)
![Page 59: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/59.jpg)
![Page 60: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/60.jpg)
![Page 61: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/61.jpg)
![Page 62: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/62.jpg)
![Page 63: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/63.jpg)
![Page 64: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/64.jpg)
![Page 65: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/65.jpg)
![Page 66: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/66.jpg)
![Page 67: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/67.jpg)
![Page 68: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/68.jpg)
![Page 69: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/69.jpg)
CR-5871 Protocol v4.0 (4) Page 69 of 141
CONFIDENTIAL
![Page 70: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/70.jpg)
![Page 71: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/71.jpg)
![Page 72: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/72.jpg)
![Page 73: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/73.jpg)
![Page 74: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/74.jpg)
![Page 75: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/75.jpg)
![Page 76: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/76.jpg)
![Page 77: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/77.jpg)
CR-5871 Protocol v4.0 (4) Page 77 of 141
CONFIDENTIAL
![Page 78: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/78.jpg)
CR-5871 Protocol v4.0 (4) Page 78 of 141
CONFIDENTIAL
![Page 79: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/79.jpg)
![Page 80: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/80.jpg)
![Page 81: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/81.jpg)
![Page 82: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/82.jpg)
![Page 83: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/83.jpg)
CR-5871 Protocol v4.0 (4) Page 83 of 141
CONFIDENTIAL
![Page 84: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/84.jpg)
![Page 85: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/85.jpg)
![Page 86: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/86.jpg)
![Page 87: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/87.jpg)
![Page 88: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/88.jpg)
![Page 89: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/89.jpg)
![Page 90: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/90.jpg)
CR-5871 Protocol v4.0 (4) Page 90 of 141
CONFIDENTIAL
![Page 91: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/91.jpg)
![Page 92: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/92.jpg)
CR-5871 Protocol v4.0 (4) Page 92 of 141
CONFIDENTIAL
![Page 93: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/93.jpg)
![Page 94: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/94.jpg)
![Page 95: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/95.jpg)
![Page 96: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/96.jpg)
![Page 97: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/97.jpg)
![Page 98: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/98.jpg)
![Page 99: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/99.jpg)
CR-5871 Protocol v4.0 (4) Page 99 of 141
CONFIDENTIAL
![Page 100: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/100.jpg)
![Page 101: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/101.jpg)
![Page 102: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/102.jpg)
![Page 103: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/103.jpg)
![Page 104: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/104.jpg)
![Page 105: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/105.jpg)
CR-5871 Protocol v4.0 (4) Page 105 of 141
CONFIDENTIAL
![Page 106: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/106.jpg)
![Page 107: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/107.jpg)
![Page 108: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/108.jpg)
![Page 109: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/109.jpg)
![Page 110: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/110.jpg)
![Page 111: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/111.jpg)
![Page 112: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/112.jpg)
CR-5871 Protocol v4.0 (4) Page 112 of 141
CONFIDENTIAL
![Page 113: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/113.jpg)
![Page 114: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/114.jpg)
![Page 115: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/115.jpg)
![Page 116: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/116.jpg)
![Page 117: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/117.jpg)
![Page 118: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/118.jpg)
![Page 119: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/119.jpg)
![Page 120: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/120.jpg)
![Page 121: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/121.jpg)
![Page 122: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/122.jpg)
CR-5871 Protocol v4.0 (4) Page 122 of 141
CONFIDENTIAL
![Page 123: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/123.jpg)
![Page 124: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/124.jpg)
![Page 125: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/125.jpg)
![Page 126: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/126.jpg)
![Page 127: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/127.jpg)
CR-5871 Protocol v4.0 (4) Page 127 of 141
CONFIDENTIAL
![Page 128: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/128.jpg)
![Page 129: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/129.jpg)
![Page 130: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/130.jpg)
![Page 131: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/131.jpg)
CR-5871 Protocol v4.0 (4) Page 131 of 141
CONFIDENTIAL
![Page 132: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/132.jpg)
![Page 133: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/133.jpg)
![Page 134: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/134.jpg)
![Page 135: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/135.jpg)
CR-5871 Protocol v4.0 (4) Page 135 of 141
CONFIDENTIAL
![Page 136: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/136.jpg)
![Page 137: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/137.jpg)
CR-5871 Protocol v4.0 (4) Page 137 of 141
CONFIDENTIAL
![Page 138: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/138.jpg)
![Page 139: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/139.jpg)
![Page 140: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/140.jpg)
![Page 141: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/141.jpg)
![Page 142: CR-5871 Protocol v4.0 REDACTED - ClinicalTrials.gov...CR-5871 Protocol v4.0 (4) Page 9 of 141 CONFIDENTIAL 6800$5< 2) .12:1 5,6.6 $1' %(1(),76 72 +80$1 68%-(&76 6HH '(6&5,37,21 2)](https://reader033.vdocuments.mx/reader033/viewer/2022050313/5f75efb105c0da199b3e139d/html5/thumbnails/142.jpg)